Skip to main content

Table 1 Demographics of the study cohort

From: FeV1 and BMI influence King’s Sarcoidosis Questionnaire score in sarcoidosis patients

  Whole cohort Female cohort (n = 97) Male cohort (n = 103)  
  Median or Mean ± SD IQR Median or Mean ± SD IQR Median or Mean ± SD IQR p (female vs male)
Age 53.3 ± 12.7   55.0 ± 12.4   51.8 ± 12.8   0.08
BMI 28.0 ± 5.3   27.5 ± 4.9   28.4 ± 5.7   0.42
FVC 98.4 83.2–108.4 98.7 84.7–106.3 98.3 83.3–109.8 0.91
TLC 86.3 75.1–95.8 85.0 74.3–95.9 87.5 75.3–95.0 0.50
DLCOsb 80.2 69.9–90.9 80.4 71.3–89.4 78.8 67.9–91.2 0.80
FEV1 85.8 74.5–99.1 86.8 75.6–98.7 84.6 74.4–99.1 0.64
GHS 67.9 51.9–80.2 69.8 58.0–81.1 64.2 49.1–79.3 0.15
GHS L 73.0 56.7–82.2 74.2 59.1–84.0 68.0 53.4–80.9 0.28
GHS E 69.4 54.4–80.6 71.7 57.8–82.1 68.3 50.0–80.6 0.30
GHS S 72.1 60.0–83.6 75.4 63.6–85.0 67.9 55.7–80.7 0.06
GHS LS 73.1 59.7–83.7 77.4 62.3–85.4 70.8 50.8–81.6 0.15
GHS LM 72.5 59.2–82.0 76.8 62.2–83.2 69.4 54.6–81.9 0.14
GHS SM 72.3 61.6–82.7 76.3 67.6–84.4 68.8 57.8–79.2 0.02
GHS LSM 74.3 60.7–83.3 78.4 64.7–84.5 71.8 58.4–80.0 0.06
LUNG 77.8 58.3–93.1 76.4 58.3–93.1 77.8 58.3–93.1 0.88
MED 84.9 54.6–100 84.9 67.7–100 77.3 54.6–100 0.13
SKIN 88.2 70.6–100 94.1 70.6–100 82.4 70.6–100 0.15
EYES 77.0 52.7–93.2 77.0 53.4–93.2 73.0 52.7–93.2 0.63
Borg 0.5 0.0–2.0 0.5 0.0–2.0 0.5 0.0–2.8 0.50
sIL2R 513.5 380–713 506.5 378.8–679.5 528.5 380–735 0.59
Neopterin 11.5 8.4–16.4 12.2 9.0–16.3 10.3 7.7–16.5 0.09
ACE 35.4 22.7–48.9 39.1 25.6–51.2 28.8 20.6–43.8 0.06
  1. Italics indicate values with borderline significance defined as 0.05
  2. Values with statistical significance defined as p < 0.05 were indicated in bold